source
- Scribe Therapeutics files for IPO in test of appetite for early-stage biotechsScribe Therapeutics filed for a Nasdaq IPO late Thursday. The move marks a pivotal moment for the biotech and the gene editing field. The novel CRISPR enzyme developer was created nine ...Endpoints · 27d ago↗ source
- Sandoz launches direct-to-consumer platform with growth disorder drugSandoz unveiled a direct-to-consumer platform, starting off with a single medication for now as the generic drugmaker adopts a system that several brand-name manufacturers are using to cut out-of-p…Endpoints · 27d ago↗ source
- After landmark deal, AstraZeneca goes to CSPC again in up to $1.7B pactLess than six months after lining up one of the largest biobucks packages in industry history, AstraZeneca is returning to the same Chinese partner for another drug R&D collaboration. The UK pharma…